| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce384cea17765179fd01cd5c80f294ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_edf89f57d3d88447aa4b3e6953841c4f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 |
| filingDate |
2019-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46ecd4c14a6eb8c98a87bbf5b63f0a84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d179f5e3cbbdd66f3e6ff0da3549d1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce4cd2ad6d1a62ea67b95e8270de5d83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a179fe1273b6e00f57ef36b90ab7ac7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8fdb45cb0839cdc60f704d9d44d3685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72f1727ae6c5c654cb4b869ef9630965 |
| publicationDate |
2021-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021015866-A1 |
| titleOfInvention |
Tissue resident memory cell profiles, and uses thereof |
| abstract |
This disclosure provides methods of treating cancer or eliciting an anti-tumor response in a subject by administering an effective amount of a population of T-cells that exhibits higher or lower than baseline expression of one or more genes. In other aspects, methods are provided to diagnose cancer and determine prognosis of cancer patients. Also provided are methods to identify the antigens or antigen receptors associated with the isolated and/or purified cell populations that elicit a more positive prognosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023064632-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022242701-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023147530-A1 |
| priorityDate |
2018-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |